Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Tan

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
ACS Nano|November 19, 2021
Noninvasive and Highly Multiplexed Five-Color Tumor Imaging of Multicore Near-Infrared Resonant Surface-Enhanced Raman Nanoparticles <i>In Vivo</i>Jung Ho Yu, Idan Steinberg, Ryan M Davis, et al.
BMJ Open|May 2, 2025
A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumoursTimothy Price, Iwona Lugowska, Sant P Chawla, et al.
The Lancet. Respiratory Medicine|November 20, 2020
Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort studyDinh S Bui, Caroline J Lodge, Jennifer L Perret, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2025
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignanciesVincent Ribrag, Lara Iglesias, Filippo De Braud, et al.
BMJ Open Respiratory Research|December 3, 2021
Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohortsJennifer L Perret, Don Vicendese, Koen Simons, et al.
Singapore Medical Journal|November 30, 2019
A practical and adaptive approach to lung cancer screening: a review of international evidence and position on CT lung cancer screening in the Singaporean population by the College of Radiologists SingaporeCharlene Jin Yee Liew, Lester Chee Hao Leong, Lynette Li San Teo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Nature Biomedical Engineering|March 7, 2025
A deep-learning model for quantifying circulating tumour DNA from the density distribution of DNA-fragment lengthsGuanhua Zhu, Chowdhury Rafeed Rahman, Victor Getty, et al.
The Lancet. Oncology|August 1, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trialYi-Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
ACS Nano|November 19, 2021
Noninvasive and Highly Multiplexed Five-Color Tumor Imaging of Multicore Near-Infrared Resonant Surface-Enhanced Raman Nanoparticles <i>In Vivo</i>Jung Ho Yu, Idan Steinberg, Ryan M Davis, et al.
BMJ Open|May 2, 2025
A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumoursTimothy Price, Iwona Lugowska, Sant P Chawla, et al.
The Lancet. Respiratory Medicine|November 20, 2020
Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort studyDinh S Bui, Caroline J Lodge, Jennifer L Perret, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2025
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignanciesVincent Ribrag, Lara Iglesias, Filippo De Braud, et al.
BMJ Open Respiratory Research|December 3, 2021
Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohortsJennifer L Perret, Don Vicendese, Koen Simons, et al.
Singapore Medical Journal|November 30, 2019
A practical and adaptive approach to lung cancer screening: a review of international evidence and position on CT lung cancer screening in the Singaporean population by the College of Radiologists SingaporeCharlene Jin Yee Liew, Lester Chee Hao Leong, Lynette Li San Teo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.
Nature Biomedical Engineering|March 7, 2025
A deep-learning model for quantifying circulating tumour DNA from the density distribution of DNA-fragment lengthsGuanhua Zhu, Chowdhury Rafeed Rahman, Victor Getty, et al.
The Lancet. Oncology|August 1, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trialYi-Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
Pageof 10